MINOLIRA

Peak

minocycline hydrochloride

NDAORALTABLET, EXTENDED RELEASE
Approved
May 2017
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
1

Clinical Trials (1)

NCT02297412Phase 2Completed

Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel

Started Nov 2014
47 enrolled
Acute PainBreast CarcinomaPeripheral Neuropathy

Loss of Exclusivity

LOE Date
Apr 7, 2036
122 months away
Patent Expiry
Apr 7, 2036

Patent Records (1)

Patent #ExpiryTypeUse Code
11103517
Apr 7, 2036
Product
—
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers